Hello, everyone, and how are you today? Another steamy morning is unfolding here on the Pharmalot corporate campus, where we are trying to keep cool with a hot cup of stimulation (this may appear counterintuitive, but we enjoy the results). Meanwhile, another busy day lies ahead. In fact, we will be speaking at anindustry conference later - wish us luck - but will do our best to maintain the usual flow of items. Here, in fact, are a few tidbits to get you going. Hope your day goes well and do stay in touch...
AstraZeneca's MedImmune To Shed 200 Jobs (San Francisco Business Times)
Fire At Merck Plant Under Investigation (Montgomery News)
Unions Complain About Former AstraZeneca CEO Pay (Manchester Evening News)
AstraZeneca To Study Brilinta Against Plavix (Bloomberg News)
Teva MS Pill Accepted For Review In Europe (Pharma Times)
EDITOR'S NOTE: Please check this post for updates during the day